The postdoc will join a collaborative team of senior scientists, postdocs, and PhD students to establish a novel iPSC-derived NK-cell platform for next-generation biotherapeutics. Key responsibilities include engineering and glycoengineering of human iPSCs into NK-cells, developing gene editing and exosome-based strategies for enhanced cellular therapeutics, and contributing to innovation in manufacturing processes for cell-based therapies.